ALBERT DAVID
|
ALBERT DAVID Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 30.14 | 132.15 | 63.38 | 61.78 | 38.80 |
| CEPS(Rs) | 42.35 | 144.11 | 78.36 | 77.21 | 53.22 |
| DPS(Rs) | 5.00 | 11.50 | 9.00 | 9.00 | 6.00 |
| Book NAV/Share(Rs) | 687.70 | 671.05 | 545.93 | 489.68 | 428.20 |
| Tax Rate(%) | 31.82 | 22.48 | 28.70 | 25.45 | 19.31 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 0.85 | 12.25 | 12.33 | 12.38 | 7.40 |
| EBIT Margin(%) | 6.94 | 25.48 | 14.23 | 14.51 | 10.84 |
| Pre Tax Margin(%) | 6.79 | 25.37 | 14.07 | 14.30 | 10.54 |
| PAT Margin (%) | 4.63 | 19.67 | 10.03 | 10.66 | 8.50 |
| Cash Profit Margin (%) | 6.51 | 21.45 | 12.40 | 13.33 | 11.66 |
| Performance Ratios | |||||
| ROA(%) | 2.80 | 13.51 | 7.33 | 8.01 | 5.51 |
| ROE(%) | 4.44 | 21.72 | 12.24 | 13.46 | 9.48 |
| ROCE(%) | 6.55 | 27.87 | 17.10 | 18.10 | 11.99 |
| Asset Turnover(x) | 0.60 | 0.69 | 0.73 | 0.75 | 0.65 |
| Sales/Fixed Asset(x) | 1.54 | 1.70 | 1.62 | 1.52 | 1.23 |
| Working Capital/Sales(x) | 1.49 | 1.41 | 1.76 | 2.26 | 1.83 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.65 | 0.59 | 0.62 | 0.66 | 0.81 |
| Receivable days | 27.87 | 28.39 | 28.00 | 24.56 | 34.76 |
| Inventory Days | 52.84 | 44.87 | 45.48 | 41.36 | 54.98 |
| Payable days | 158.48 | 132.65 | 130.63 | 115.22 | 164.75 |
| Valuation Parameters | |||||
| PER(x) | 26.92 | 8.14 | 8.08 | 8.61 | 9.71 |
| PCE(x) | 19.16 | 7.46 | 6.53 | 6.89 | 7.08 |
| Price/Book(x) | 1.18 | 1.60 | 0.94 | 1.09 | 0.88 |
| Yield(%) | 0.62 | 1.07 | 1.76 | 1.69 | 1.59 |
| EV/Net Sales(x) | 1.36 | 1.61 | 0.80 | 0.92 | 0.73 |
| EV/Core EBITDA(x) | 14.40 | 5.59 | 4.54 | 5.10 | 4.97 |
| EV/EBIT(x) | 18.29 | 5.99 | 5.29 | 6.03 | 6.42 |
| EV/CE(x) | 1.17 | 1.52 | 0.86 | 0.61 | 0.45 |
| M Cap / Sales | 1.34 | 1.69 | 0.86 | 0.97 | 0.87 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -4.61 | 6.12 | 8.95 | 26.70 | -22.86 |
| Core EBITDA Growth(%) | -68.68 | 74.62 | 5.45 | 55.72 | -3.07 |
| EBIT Growth(%) | -73.62 | 90.41 | 6.98 | 69.94 | -5.72 |
| PAT Growth(%) | -77.19 | 108.49 | 2.60 | 59.23 | 15.52 |
| EPS Growth(%) | -77.19 | 108.49 | 2.60 | 59.23 | 15.52 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.03 | 0.01 | 0.02 | 0.02 | 0.01 |
| Current Ratio(x) | 2.15 | 2.33 | 2.09 | 1.81 | 2.05 |
| Quick Ratio(x) | 1.86 | 2.11 | 1.82 | 1.59 | 1.79 |
| Interest Cover(x) | 47.11 | 226.30 | 87.91 | 71.35 | 36.00 |
| Total Debt/Mcap(x) | 0.02 | - | 0.02 | 0.02 | 0.01 |
Compare Financial Ratios of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹459.4 Cr | 0.2% | -11.5% | -34.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,498.0 Cr | 0.6% | -2.4% | -7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,838.0 Cr | -0.3% | -7.6% | 23% | Stock Analytics | |
| CIPLA | ₹129,330.0 Cr | 1.8% | 8.1% | -0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹124,235.0 Cr | 0.9% | 3.7% | 8.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,211.0 Cr | 1% | 2.4% | -9.6% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | 0.2% |
-11.5% |
-34.7% |
| SENSEX | 0.5% |
-1.3% |
0.9% |
You may also like the below Video Courses
